Immunogenetics of systemic lupus erythematosus in Spanish patients: differential HLA markers.
HLA-DR3 antigen included in the compound phenotype B18BfF1 (but not the one linked to the B8BfS compound phenotype) was found to be significantly increased in our SLE patients. It is remarkable that in our Southern-Mediterranean population, B18BfF1DR3 individuals (but not B8BfSDR3) are prone to SLE with renal disease, in contrast with other Northern European and Caucasoid populations. Also, patients with autoantibodies to Ro/La have a significant increase of the B8DR3 compound phenotype. Production of autoantibodies against Ro alone was associated to DR2 and production of anti-Sm/nRNP to DR3 (either B18BfF1 or B8BfS associated) only in the subgroup without renal disease. The distinctive HLA and autoimmune associations to SLE with and without renal disease suggests that both clinical forms may not share a common identical pathogenesis.
Gómez-Reino
J J
JJ
Department of Immunology, University of Alcala de Henares, Madrid, Spain.
Martínez-Laso
J
J
Vicario
J L
JL
Paz-Artal
E
E
Aragón
A
A
Martín-Villa
J M
JM
De Juan
M D
MD
Pérez-Aciego
P
P
Arnaiz-Villena
A
A
D001323:Autoantibodies; D006680:HLA Antigens / Q000032:analysis*; D015235:HLA-B Antigens / Q000032:analysis; D015236:HLA-C Antigens / Q000032:analysis; D015395:Histocompatibility Antigens Class I / Q000032:analysis; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006650:Histocompatibility Testing; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000235:genetics* / Q000276:immunology; D010641:Phenotype; D013030:Spain
D001323:Autoantibodies; D006680:HLA Antigens; D015235:HLA-B Antigens; C048259:HLA-Bf antigen; D015236:HLA-C Antigens; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II